HIV care study aims to keep patients on track in first six months

NCT ID NCT05454852

Ongoing Knowledge-focused Sponsor: Boston University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study surveys 771 adults with HIV in Zambia who have started or restarted antiretroviral therapy (ART) within the last six months. Researchers want to learn what services and support patients prefer during this critical early period, when many drop out of care. The goal is to use this information to design better care models that help patients stay healthy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help design better, more patient-friendly HIV care models for the early treatment period, potentially improving retention and health outcomes.
What could go wrong: This is an observational study, not a treatment trial. It gathers information but does not test a new drug or therapy, so direct patient benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Show contact details

Locations

Clinton Health Access Initiative

Lusaka, Zambia
Mhairi Maskew

Johannesburg, Gauteng, 2193, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.